A rapidly testable novel Magnetically-Driven Ventricular Assist Device (MVAD)
with no m ving parts that can be used to provide assistance to the cardiovascular circulation
while reducing caval pressure in patients who have undergone the Fontan procedure to palliate the
Hypoplastic Left Heart Syndrome (HLHS) is proposed and studied. A benchtop Mock Flow Loop (MFL) of
the cardiovascular circulation with a Fontan total cavopulmonary connection (TCPC) is configured to
validate this hypothesis. The MFL is based on a Lumped-Parameter Model (LPM) comprised of upper
and lower systemic circulation as well as left and right pulmonary circulation
compartments. Needle valves are used to accurately replicate vascular resistance (R) while
compliance chambers are used to mimic vascular compliance (C). The MFL centerpiece is the
truncated aortic arch with an implanted MVAD. A ferro-fluid solution is mixed in water to simulate
magnetically-charged blood. The pulsating flow is induced by drawing the ferro-fluid from a main
reservoir with a Harvard Apparatus Medical pump while the MVAD provides assistive momentum to
the TCPC. Flow and pressure sensor data at specific points in the MFL are acquired
via a National Instruments multichannel data acquisition board and processed using LabView.
Different prototypes of the MVAD are tested to validate the hypothesis
